CHIPPS WP6
Research type
Research Study
Full title
Care Homes Independent Pharmacist Prescribing Service (CHIPPS): A cluster randomised controlled trial to determine both its effectiveness and cost-effectiveness. Work Package 6: RCT with internal pilot: a definitive randomised controlled trial
IRAS ID
232474
Contact name
Clare Symms
Contact email
Sponsor organisation
NHS South Norfolk CCG
Duration of Study in the UK
2 years, 7 months, 27 days
Research summary
The use of medicines in care homes could be improved and as a result the health of residents should be better.
Pharmacist prescribers (i.e. pharmacists specifically accredited to prescribe in a similar way to doctors), have already been shown to provide high quality care, which is safe and well received. We propose to test if making pharmacist prescribers part of the care home team, working alongside general practitioners, could improve the use of medicines and the care of residents.
These pharmacist prescribers would sign and order monthly prescriptions whilst carefully monitoring how each resident responds. We believe that such a change to the management of medicines in care homes is likely to be a good use of NHS money. However, to develop and test this idea in the best way possible we need to undertake six inter-linked work packages (WP). This application is for WP6 of this programme which is a randomised controlled study (with internal pilot) following WP5 which was a feasibility study which tested the delivery of the service to 40 participants.REC name
Scotland A: Adults with Incapacity only
REC reference
17/SS/0118
Date of REC Opinion
8 Nov 2017
REC opinion
Favourable Opinion